ACE2 and COVID-19: The current study sought to assess the impact of ACE and ACE2 polymorphisms on the prognosis of COVID-19 patients with a confirmed diagnosis of SARS-CoV-2 infection being treated in a field hospital in Goiânia, GO, Brazil.